-
LUCE, AMONG THE MAIN COLLABORATORS OF 3RD ESO MASTERCLASS IN CANCER PATIENT ADVOCACY
This third edition of the Masterclass brought together senior representatives of European and international cancer patient networks as well as a small number of future…
-
EUROPEAN CANCER ORGANISATION (ECCO) RAISING AWARENESS ABOUT QUALITY OF CANCER CARE
Lung Cancer Europe joins European CanCer Organisation (ECCO) efforts to raising awareness and debate stimulation on the topic of quality of cancer care: what it consists of;…
-
INTERVIEW WITH HEALTH EUROPE QUATERLY
Stefania Vallone, LuCE president, spoke to Health Europe Quaterly about the disparities and barriers that remain in access to innovative lung cancer diagnostics, drugs, and…
-
LAUNCH OF LUCE CALL TO ACTION CAMPAIGN
Lung Cancer Europe (LuCE) marked the World Cancer Day by launching the European Call to Action Campaign. The call highlights the existing disparities in access…
-
PETITION: LET’S REDUCE DISPARITIES IN LUNG CANCER: WHAT MUST WE DO?
Lung Cancer Europe (LuCE) represents lung cancer patients and caregivers, no matter the place they live, and we advocate for the best support as possible…
-
LUCE + EUPATI PATIENT ADVOCACY WEBINAR
Lung Cancer Europe and the European Patients’ Academy for Therapeutic Innovation EUPATI have jointly organised this webinar on the theory and some practical examples of…
-
LUNG CANCER EUROPE REPORT LAUNCHED IN THE EU PARLIAMENT – LETS REDUCE DISPARITIES: WHAT MUST WE DO?
PRESS RELEASE : For the second consecutive year, the Lung Cancer Europe Report was officially launched during an event in the EU Parliament, hosted by Mr. Alojz…
-
DISPARITIES IN DIAGNOSIS, CARE AND TREATMENT ACCESS
November 7 th 2017: LuCE report on Lung Cancer After the 1st LuCE Report in 2016, in which we highlighted the main challenges in lung cancer…
-
WHAT IS PET-CT? AN ILLUSTRATED ANIMATION – LUNG NODULE CASE
PET-CT plays a vital role in diagnosis & therapy of disease. An initiative of the AIPES Nuclear Medicine Awareness Working Group.